You Young Pharmaceutical announced on the 8th that it has signed an export contract with Taiwanese and Indonesian pharmaceutical companies for the osteoarthritis injection "Lecino1" and started its first export.
RecinoOne is a domestic new drug hyaluronic acid osteoarthritis injection developed by You Young Pharmaceutical with its own technology.
It has become a treatment for osteoarthritis patients by improving persistence by administering it once every six months, reducing pain when injected, which is the biggest burden on patients.
You Young Pharmaceutical said it achieved the first order of Resinawon by completing license registration in Taiwan and Indonesia, and explained that it plans to increase sales significantly through local marketing activities after launching in each country.
It will also export to Chile and Hong Kong in February.
An official from the company said, "LecinoOne will become the largest export sales item through the development of new national clients," adding, "As the demand for single-dose injections increases worldwide, You Young Pharmaceutical will actively pursue sales activities to expand LecinoOne's global market."
[WIKI KOREA=Cho Eun, Reporter]
choeun@wikileaks-kr.org
